|
Nearly all women experience side effects as a result of breast
cancer treatments but some may not be getting sufficient medical
attention, according to researchers at the Cancer Research Campaign
in England.
A new study
has shown a wide variation in the kinds of side effects and symptoms
women experience when taking drugs such as tamoxifen and goserelin.
The study, part of a wider study of treatment with tamoxifen and
goserelin, included 75 patients taking one or both drugs, comparing
the symptoms they reported with those recorded on their medical
charts.
"The
results were striking," said Lesley Fallowfield, professor
at the Royal Free and University College Medical Center and lead
researcher.
Researchers
found that the symptoms in the medical notes often varied considerably
from those described by the patients. While 99 percent of women
experienced symptoms as a result of therapy, only 89 percent had
some kind of side effect recorded in their medical notes.
"Clearly
some side effects are being overlooked. And that could well be
because our over-stretched cancer doctors simply don't have the
time to spend listening to their patients about how they are feeling,"
said Fallowfield.
There was
a significant difference between the frequency of symptoms recorded
by the doctor and those self-reported by the patients. As many
as 91 percent of the women believed their treatment caused hot
flushes, but only 47 percent of the records noted the complaint.
Eighty percent of the patients reported gaining weight but this
was only reported on 21 percent of the medical notes.
"Some
patients don't have a clear idea of what counts as a side effect,"
reported Fallowfield. Part of the problem could be a matter of
terminology.
"In at
least one case the interviewee told us she hadn't had any side
effects, but when we showed her a list of common symptoms she
found she'd had several of them," said Fallowfield.
Fallowfield
stressed the need for doctors to be trained in communication skills
to make sure that cancer patients are not suffering in silence.
Patients cannot make an informed decision about which treatment
is best for them without knowing the full effects of the treatment.
Other
Sources: Cancer Research Campaign
|